ESC & iPSC News Volume 17.43 | Nov 09 2022

    0
    88








    2022-11-09 | ESC & iPSC 17.43


    ESC & iPSC News by STEMCELL Technologies
    Vol. 17.43 – 9 November, 2022
    TOP STORY

    Transcription Factor Antagonism Regulates Heterogeneity in Embryonic Stem Cell States

    Scientists characterized the regulatory program underlying heterogeneity in mESC states by identifying differentially active and transcribed enhancers across states.
    [Molecular Cell]

    Full ArticleGraphical Abstract
    ON1104SM-Small-Molecules-Wallchart-728x90
    PUBLICATIONSRanked by the impact factor of the journal

    Membrane Potential Drives the Exit from Pluripotency and Cell Fate Commitment via Calcium and mTOR

    Researchers showed that membrane voltage regulated the exit from pluripotency and the onset of germ layer differentiation in the embryo, a process that affected both gastrulation and left-right patterning.
    [Nature Communications]

    Full Article

    Lamin A/C-Dependent Chromatin Architecture Safeguards Naïve Pluripotency to Prevent Aberrant Cardiovascular Cell Fate and Function

    The authors showed that lamin A/C played a key role in chromatin organization in ESCs, which safeguarded naïve pluripotency and ensured proper cell fate choices during cardiogenesis.
    [Nature Communications]

    Full Article

    Platr4 Is an Early Embryonic lncRNA That Exerts Its Function Downstream on Cardiogenic Mesodermal Lineage Commitment

    Investigators demonstrated that perturbation of an ESC/early embryonic long non-coding RNA (lncRNA), pluripotency-associated transcript 4 (Platr4), directly influenced the specification of cardiac-mesoderm-lineage differentiation.
    [Developmental Cell]

    AbstractGraphical Abstract

    Mammalian CDC14 Phosphatases Control Exit from Stemness in Pluripotent Cells

    Researchers reported that exit from stemness and differentiation of pluripotent cells along the neural lineage were controlled by CDC14, a cyclin-dependent kinase-counteracting phosphatase.
    [EMBO Journal]

    AbstractGraphical Abstract

    A Gene Subset Requires CTCF Bookmarking during the Fast Post-Mitotic Reactivation of Mouse ES Cells

    Scientists showed that mESCs, which displayed rapid cell cycles and spent little time in G1, also displayed accelerated reactivation dynamics that lacked specificity towards functional gene families, enabling the restoration of all regulatory functions before DNA replication.
    [EMBO Reports]

    Full ArticleGraphical Abstract

    Virtual Cells in a Virtual Microenvironment Recapitulate Early Development-Like Patterns in Human Pluripotent Stem Cell Colonies

    Investigators developed a minimal gene regulatory network model of hPSC lineage commitment and embedded it into “cellular” agents that responded to a dynamic morphogenetic signaling microenvironment.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Stabilization of hESCs in Two Distinct Substates along the Continuum of Pluripotency

    The authors derived four hESC lines in naïve human stem cell medium (NHSM), and generated isogenic pairs of NHSM and primed cultures. Through phenotypic, transcriptomic, and methylation profiling, they identified changes that arose during the transition to a primed substate.
    [iScience]

    AbstractGraphical Abstract

    Epigenetic Mechanisms of Strip2 in Differentiation of Pluripotent Stem Cells

    Researchers identified several interaction partners of Strip2, one component of the striatin-interacting phosphatase and kinase complex, which was primarily involved in the regulation of the pluripotency of ESCs and their differentiation.
    [Cell Death Discovery]

    Full Article

    Acute Severe Hypoxia Induces Apoptosis of Human Pluripotent Stem Cells by a HIF-1α and P53 Independent Mechanism

    Scientists explored the consequences of acute hypoxia on hPSC survival by culturing them under acute physical severe hypoxia.
    [Scientific Reports]

    Full Article
    STEMCELL has implemented an Environmental Management System that is now ISO 14001-certified.
    REVIEWS

    Engineered and Banked iPSCs for Advanced NK and T Cell Immunotherapies

    The authors highlight recent progress in iPSC editing and guided differentiation to develop natural killer (NK) and T cell products for immunotherapy.
    [Blood]

    Abstract
    INDUSTRY AND POLICY NEWS

    US Agency Seeks to Phase Out Animal Testing

    The FDA committed to exploring alternative methods to replace laboratory animals in developing new drugs and products.
    [Nature News]

    Press Release
    FEATURED EVENT

    Balancing Genome Fidelity and Plasticity

    May 4 – 7, 2023
    Riviera Maya, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientist – Regenerative Therapy

    Berlin Institute of Health – Berlin, Germany

    Research Scientist – iPSC Disease Modeling

    Lifespan – Providence, Rhode Island, United States

    Postdoctoral Fellow – Mammalian Morphogenesis

    UC San Francisco – San Francisco, California, United States

    Postdoctoral Researcher – Stem Cell Therapy for Osteoarthritis

    University of Galway – Galway, Ireland

    Scientist – iPSC and CRISPR

    Icahn School of Medicine at Mount Sinai – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter